Investment guidance :: due diligence

Due Diligence Taken To a New Level...
With corroborative value analysis and statistical risk assessment

It's time to know more.

The Parenteau BioConsultants & BioRankings Alliance

With dramatic changes in the financial markets and the rising cost of bioscience development amounting to hundreds of millions of dollars invested in each product candidate, there is a pressing need for unbiased, comprehensive and corroborative due diligence that can guide private capital and public investment to the strongest life science opportunities. Parenteau BioConsultants and BioRankings are helping to address this need with a new brand of due diligence to meet the needs of life science in 2010 and beyond.

By combining Parenteau BioConsultants’ expertise in biological and immunological science, life science management and concept-to-market development with BioRankings’ broad expertise in biostatistics that encompasses many complex medical areas, the alliance can assess technical value and risk in a uniquely comprehensive and corroborative way.

Together, Parenteau BioConsultants and BioRankings can provide analysis that examines key factors that impact the ability to generate commercial output including:

the likelihood of reaching therapeutic effectiveness based on scientific and medical validity and statistical due diligence of existing data

the comparative strength of a company’s technology and commercial strategy

the quality of a company’s life science management practices

Helping investors direct their investments to the most valuable opportunites (pdf)

Helping companies demonstrate and validate their value to attract investment (pdf)

For more rewarding life science:

Talk to us about your investment opportunities...

Talk to us about your biotechnology company...

Investment guidance, biologics due diligence, cancer immunotherapy

To learn more about our corroborative approach to biotechnology due diligence, we invite you to read the free Alliance ebook:

Immunotherapy Demystified: Investing in High Risk, High Reward Opportunities in Cancer Therapeutics.

ABOUT BIORANKINGS LLC

BioRankings LLC is a biostatistical consulting service company that makes complex biostatistical ideas understandable. Founded by Dr. William Shannon, Associate Professor of Biostatistics in Medicine, Washington University School of Medicine in St. Louis, BioRankings LLC brings over 20 years of applied biostatistical expertise in biomedical, pharmaceutical, and biotech research. In addition to over 80 peer-reviewed publications in diverse areas such as oncology, pediatrics, genetics, cardiology, pulmonology, infectious disease, sleep medicine, health care delivery, and many other areas, the BioRankings LLC staff have advanced technical expertise in biotechnology, genetics, cell and molecular biology, and technical writing. Additional information about BioRankings can be found at www.BioRankings.com.